BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12810345)

  • 1. Cerebellar volume and long-term use of phenytoin.
    De Marcos FA; Ghizoni E; Kobayashi E; Li LM; Cendes F
    Seizure; 2003 Jul; 12(5):312-5. PubMed ID: 12810345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cerebellar atrophy and phenytoin poisoning. An MR study].
    Luef G; Marosi M; Felber S; Birbamer G; Aichner F; Bauer G
    Nervenarzt; 1993 Aug; 64(8):548-51. PubMed ID: 8413755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dose-dependent relationship of chronic use of phenytoin and cerebellar atrophy in patients with epilepsy].
    Del Negro A; Dantas CD; Zanardi V; Montenegro MA; Cendes F
    Arq Neuropsiquiatr; 2000 Jun; 58(2A):276-81. PubMed ID: 10849627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with extratemporal lobe epilepsy do not differ from healthy subjects with respect to subcortical volumes.
    Gärtner B; Seeck M; Michel CM; Delavelle J; Lazeyras F
    J Neurol Neurosurg Psychiatry; 2004 Apr; 75(4):588-92. PubMed ID: 15026503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebellar atrophy in an epileptic child: is it due to phenytoin?
    Ahuja SR; Karande S; Kulkarni MV
    J Postgrad Med; 2000; 46(4):278-9. PubMed ID: 11435657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion tensor MRI and fiber tractography of cerebellar atrophy in phenytoin users.
    Lee SK; Mori S; Kim DJ; Kim SY; Kim SY; Chu M; Heo K; Lee BI; Kim DI
    Epilepsia; 2003 Dec; 44(12):1536-40. PubMed ID: 14636324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised controlled trial to assess acceptability of phenobarbital for childhood epilepsy in rural India.
    Pal DK; Das T; Chaudhury G; Johnson AL; Neville BG
    Lancet; 1998 Jan; 351(9095):19-23. PubMed ID: 9433424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of phenytoin and pheneturide in patients with epilepsy: a double-blind cross-over trial.
    Gibberd FB; Park DM; Scott G; Gawel MJ; Fry DE; Page NG; Engler C; English JR; Rose FC
    J Neurol Neurosurg Psychiatry; 1982 Dec; 45(12):1113-8. PubMed ID: 6819339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance volumetry of the cerebellum in epileptic patients after phenytoin overdosages.
    Luef G; Burtscher J; Kremser C; Birbamer G; Aichner F; Bauer G; Felber S
    Eur Neurol; 1996; 36(5):273-7. PubMed ID: 8864707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of epilepsy: overview and general principles.
    Sibley WA
    Pediatrics; 1974 Apr; 53(4):531-5. PubMed ID: 4150880
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anticonvulsive pharmacotherapy may aggravate epilepsy course].
    Zenkov LR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(10):52-4. PubMed ID: 16281381
    [No Abstract]   [Full Text] [Related]  

  • 12. The treatable epilepsies. (First of Two Parts).
    Delgado-Escueta AV; Treiman DM; Walsh GO
    N Engl J Med; 1983 Jun; 308(25):1508-14. PubMed ID: 6406889
    [No Abstract]   [Full Text] [Related]  

  • 13. Cerebellar atrophy in patients with long-term phenytoin exposure and epilepsy.
    Ney GC; Lantos G; Barr WB; Schaul N
    Arch Neurol; 1994 Aug; 51(8):767-71. PubMed ID: 8042924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenytoin monotherapy for epilepsy: a long-term prospective study, assisted by serum level monitoring, in previously untreated patients.
    Reynolds EH; Shorvon SD; Galbraith AW; Chadwick D; Dellaportas CI; Vydelingum L
    Epilepsia; 1981 Aug; 22(4):475-88. PubMed ID: 6790274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Entorhinal cortex MRI assessment in temporal, extratemporal, and idiopathic generalized epilepsy.
    Bernasconi N; Andermann F; Arnold DL; Bernasconi A
    Epilepsia; 2003 Aug; 44(8):1070-4. PubMed ID: 12887438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenytoin and phenobarbitone plasma clearance during pregnancy.
    Mygind KI; Dam M; Christiansen J
    Acta Neurol Scand; 1976 Aug; 54(2):160-6. PubMed ID: 821304
    [No Abstract]   [Full Text] [Related]  

  • 17. [Folic-acid deficiency due to long-term anticonvulsant therapy as a causal factor of cerebellar degeneration (author's transl)].
    Meyer-Wahl L
    Nervenarzt; 1980 Oct; 51(10):619-22. PubMed ID: 6779215
    [No Abstract]   [Full Text] [Related]  

  • 18. Adrenal cortex hormones in male epileptic patients before and during a 2-year phenytoin treatment.
    Ostrowska Z; Buntner B; Rościszewska D; Guz I
    J Neurol Neurosurg Psychiatry; 1988 Mar; 51(3):374-8. PubMed ID: 3129539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Single daily dose of diphenylhydantoin in treating epilepsy].
    Shen DL
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Jun; 18(3):145-7. PubMed ID: 3932025
    [No Abstract]   [Full Text] [Related]  

  • 20. Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy.
    de Silva M; MacArdle B; McGowan M; Hughes E; Stewart J; Neville BG; Johnson AL; Reynolds EH
    Lancet; 1996 Mar; 347(9003):709-13. PubMed ID: 8601999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.